CRABP2 and colorectal carcinoma: In addition, by binding to the m‐AAA domain of AFG3L2, cytoplasmic CRABP2 can block the degradation of SLC25A39, leading to increased GSH levels, which, in turn, promote CRC cell proliferation and inhibition of apoptosis (Figure 6; Figure S5, Supporting Information).